Makati
Philippines
Phone Number
0962 950 7814
(02) 8637-2360
Send Your Mail
slcelitemedicalcare@gmail.com
Philippines
0962 950 7814
(02) 8637-2360
slcelitemedicalcare@gmail.com
What Is Next-Generation Sequencing (NGS)?
Next-Generation Sequencing (NGS) is a powerful technology that reads the genetic blueprint of your cancer—identifying the specific mutations, markers, and vulnerabilities that make your tumor unique.
Think of it as a high-tech detective that looks at hundreds of clues at once to create a complete picture of your cancer.
Traditional Testing | NGS |
|---|---|
Tests 1–5 genes at a time | Tests hundreds of genes at once |
May miss rare mutations | Captures all mutations |
Multiple biopsies may be needed | One sample gives complete picture |
Slower results | Faster turnaround |
Imagine your cancer is a book with many chapters. Traditional testing reads one page at a time. NGS reads the entire book at once—finding every typo, missing page, or hidden message that matters.
Step | What Happens |
|---|---|
1. Sample Collection | A small piece of tumor (biopsy) or a simple blood draw (liquid biopsy) is taken |
2. DNA Extraction | The genetic material is extracted from your cancer cells |
3. Sequencing | Advanced machines read hundreds of genes simultaneously |
4. Analysis | Specialists interpret the results to find actionable mutations |
NGS identifies:
✅ Driver Mutations – The genetic changes that cause cancer to grow
✅ Targetable Mutations – Genes that can be treated with precision drugs
✅ Resistance Mutations – Why cancer stopped responding to treatment
✅ Tumor Mutational Burden (TMB) – How many mutations your cancer has (helps predict immunotherapy response)
✅ MSI Status – Whether your cancer may respond to certain immunotherapies
✅ Hereditary Mutations – Genetic changes you inherited that increase cancer risk
NGS can be performed on a simple blood draw (liquid biopsy), which:
✅ Avoids invasive tissue biopsy
✅ Captures tumor DNA circulating in the blood
✅ Monitors treatment response in real-time
✅ Detects emerging resistance early
✅ Ideal for patients who cannot undergo tissue biopsy
Cancer Type | What NGS Reveals |
|---|---|
Lung Cancer | EGFR, ALK, ROS1, RET, MET, KRAS, NTRK, TMB |
Breast Cancer | HER2, BRCA1/2, PIK3CA, ESR1, MSI |
Colorectal Cancer | RAS, BRAF, MSI, NTRK, HER2 |
Prostate Cancer | BRCA1/2, ATM, MSI, AR mutations |
Ovarian Cancer | BRCA1/2, MSI, HRD |
Melanoma | BRAF, NRAS, c-KIT, TMB |
Blood Cancers | FLT3, IDH1/2, KMT2A, and many others |
Pancreatic Cancer | KRAS, BRCA, MSI, NTRK |
✅ Comprehensive – Hundreds of genes tested at once
✅ Fast – Results in days to weeks
✅ Actionable – Guides targeted therapy, immunotherapy, and clinical trial options
✅ Non-Invasive Option – Liquid biopsy available
✅ Cost-Effective – Avoids ineffective treatments
✅ Personalized – Treatment designed around YOUR cancer’s unique genetics